Suggested Results (more)

Diseases (more)

Doctors (more)

Locations (more)

News and Stories (more)

Clinical Trials (more)

Research Labs (more)

Other Results (more)

See All Results

Clinical Trials

and/or

65 Clinical Trials found

A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma

Eligibility
Paul A. Hamlin

A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma

Eligibility
Shari B. Goldfarb

A Phase I Study of ADCT-301 in Patients with Persistent or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Eligibility
Steven M. Horwitz

A Phase I Study of an Arginine Methyltransferase Inhibitor (PRMT5, GSK3326595) in Patients with Solid Tumors and Non-Hodgkin Lymphoma

Eligibility
Mrinal M. Gounder

A Phase I Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Recurrent or Persistent Mantle Cell Lymphoma

Eligibility
Anita Kumar

A Phase I Study of BTCT4465A Immunotherapy in Patients with Recurrent or Persistent B-cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Eligibility
Matthew J. Matasar

A Phase I Study of Carfilzomib plus Cyclophosphamide and Etoposide for Children with Recurrent or Persistent Solid Tumors and Leukemias

Eligibility
Tanya M. Trippett

A Phase I Study of DS-3032B in Patients with Advanced Solid Tumors or Lymphomas

Eligibility
Mrinal M. Gounder

A Phase I Study of Duvelisib with Either Romidepsin or Bortezomib for Recurrent or Persistent T-Cell Lymphoma

Eligibility
Steven M. Horwitz

A Phase I Study of Hu5F9-G4 Immunotherapy in Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma

Eligibility
Steven M. Horwitz
Narrow your choices Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.
Reset